|
× |
 |
The Prevention of Recurrent Episodes of Depression With Venlafaxine for Two Years (PREVENT) Study: Outcomes From the 2-Year and Combined Maintenance Phases PDF |
$40.00 |
|
$40.00 |
|
× |
|
Treatment of Bulimia Nervosa With Topiramate in a Randomized, Double-Blind, Placebo-Controlled Trial, Part 1: Improvement in Binge and Purge Measures PDF |
$40.00 |
|
$40.00 |
|
× |
|
Prediction of Suicidal Behavior in Clinical Research by Lifetime Suicidal Ideation and Behavior Ascertained by the Electronic Columbia-Suicide Severity Rating Scale PDF |
$40.00 |
|
$40.00 |
|
× |
|
Maintenance of Efficacy of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder: Randomized Withdrawal Design PDF |
$40.00 |
|
$40.00 |
|
× |
|
Extended-Release Bupropion for Patients With Major Depressive Disorder Presenting With Symptoms of Reduced Energy, Pleasure, and Interest: Findings From a Randomized, Double-Blind, Placebo-Controlled Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Treatment of Bulimia Nervosa With Topiramate in a Randomized, Double-Blind, Placebo-Controlled Trial, Part 2: Improvement in Psychiatric Measures PDF |
$40.00 |
|
$40.00 |
|
× |
|
Incretin Therapies: A New Tool to Combat Metabolic Consequences of Antipsychotic Use PDF |
$40.00 |
|
$40.00 |
|
|
